473 related articles for article (PubMed ID: 29215091)
1. Cancer induction and suppression with transcriptional control and epigenome editing technologies.
Nakade S; Yamamoto T; Sakuma T
J Hum Genet; 2018 Feb; 63(2):187-194. PubMed ID: 29215091
[TBL] [Abstract][Full Text] [Related]
2. Epigenome Editing in the Brain.
Bashtrykov P; Jeltsch A
Adv Exp Med Biol; 2017; 978():409-424. PubMed ID: 28523558
[TBL] [Abstract][Full Text] [Related]
3. Editing the Epigenome: Reshaping the Genomic Landscape.
Holtzman L; Gersbach CA
Annu Rev Genomics Hum Genet; 2018 Aug; 19():43-71. PubMed ID: 29852072
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas mediated epigenome editing for cancer therapy.
Ansari I; Chaturvedi A; Chitkara D; Singh S
Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
[TBL] [Abstract][Full Text] [Related]
5. Advances of epigenetic editing.
Gjaltema RAF; Rots MG
Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
[TBL] [Abstract][Full Text] [Related]
6. Entering the post-epigenomic age: back to epigenetics.
Bultmann S; Stricker SH
Open Biol; 2018 Mar; 8(3):. PubMed ID: 29593118
[TBL] [Abstract][Full Text] [Related]
7. Editing the Epigenome to Tackle Brain Disorders.
Liu XS; Jaenisch R
Trends Neurosci; 2019 Dec; 42(12):861-870. PubMed ID: 31706628
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
9. Allele-Specific Epigenome Editing.
Bashtrykov P; Jeltsch A
Methods Mol Biol; 2018; 1767():137-146. PubMed ID: 29524132
[TBL] [Abstract][Full Text] [Related]
10. Epigenome Editing: State of the Art, Concepts, and Perspectives.
Kungulovski G; Jeltsch A
Trends Genet; 2016 Feb; 32(2):101-113. PubMed ID: 26732754
[TBL] [Abstract][Full Text] [Related]
11. In vivo locus-specific editing of the neuroepigenome.
Yim YY; Teague CD; Nestler EJ
Nat Rev Neurosci; 2020 Sep; 21(9):471-484. PubMed ID: 32704051
[TBL] [Abstract][Full Text] [Related]
12. Chromatin Manipulation and Editing: Challenges, New Technologies and Their Use in Plants.
Fal K; Tomkova D; Vachon G; Chabouté ME; Berr A; Carles CC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419220
[TBL] [Abstract][Full Text] [Related]
13. Editing the epigenome: technologies for programmable transcription and epigenetic modulation.
Thakore PI; Black JB; Hilton IB; Gersbach CA
Nat Methods; 2016 Feb; 13(2):127-37. PubMed ID: 26820547
[TBL] [Abstract][Full Text] [Related]
14. Epigenome editing in cancer: Advances and challenges for potential therapeutic options.
Lee SW; Frankston CM; Kim J
Int Rev Cell Mol Biol; 2024; 383():191-230. PubMed ID: 38359969
[TBL] [Abstract][Full Text] [Related]
15. Generation of TALE-Based Designer Epigenome Modifiers.
Nitsch S; Mussolino C
Methods Mol Biol; 2018; 1767():89-109. PubMed ID: 29524130
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-based reagents to study the influence of the epigenome on gene expression.
Lavender P; Kelly A; Hendy E; McErlean P
Clin Exp Immunol; 2018 Oct; 194(1):9-16. PubMed ID: 30030848
[TBL] [Abstract][Full Text] [Related]
17. A versatile reporter system for multiplexed screening of effective epigenome editors.
Roman Azcona MS; Fang Y; Carusillo A; Cathomen T; Mussolino C
Nat Protoc; 2020 Oct; 15(10):3410-3440. PubMed ID: 32887975
[TBL] [Abstract][Full Text] [Related]
18. Greater Than the Sum of Parts: Complexity of the Dynamic Epigenome.
Soshnev AA; Josefowicz SZ; Allis CD
Mol Cell; 2016 Jun; 62(5):681-94. PubMed ID: 27259201
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
Semi K; Yamada Y
Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic editing: Dissecting chromatin function in context.
Policarpi C; Dabin J; Hackett JA
Bioessays; 2021 May; 43(5):e2000316. PubMed ID: 33724509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
